Back to FMR LLC FMR LLC

INOINO
Showing 8 of 10 quarters

Position history for FMR LLCFMR LLC's holdings in INOVIO PHARMACEUTICALS INC

Yes. FMR holds 8,454,797 shares of INO (Inovio Pharmaceuticals), worth $9.3M, as of its Q2 2026 13F filing. It reduced the position by 884,817 shares (-9.5%) from Q1 2026. FMR has held INO in every 13F on record since Q1 2024, 10 quarterly filings.

Current Value

$9.3M

Current Shares

8.5M

Total Value Change

+$9.1M

Total Shares Change

+8.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8.5M
-9.5%
$9.3M0.0%$1.10
0
2026-Q1
Decreased
9.3M
-5.2%
$16.3M0.0%$1.74
0
2025-Q4
Increased
9.8M
+7568x
$17.1M0.0%$1.74
46
2025-Q3
Decreased
1,301
-98.5%
$3,0440.0%$2.34
0
2025-Q2
Decreased
87,344
-13.2%
$177,7450.0%$2.04
0
2025-Q1
Increased
100,675
+23.7%
$164,1010.0%$1.63
19
2024-Q4
Increased
81,380
+198.5%
$148,9250.0%$1.83
25
2024-Q3
Increased
27,261
+370.1%
$157,5680.0%$5.78
25

Other major holders of INO: BlackRock Finance, Inc., BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used